Jump to content

Study finds COVID-19 patients who took hydroxychloroquine were less likely to die


Geee

Recommended Posts

study-finds-covid-19-patients-who-took-hydroxychloroquine-were-less-likely-to-die

Newly released research found that coronavirus patients who took the anti-malarial drug hydroxychloroquine were more likely to survive while being treated in a hospital.

 

The study, conducted by the Henry Ford Health System in southeast Michigan, measured the mortality rates and treatments of 2,541 patients representing a mix of races, genders, and ages. The research team found that 26% of patients who were not given hydroxychloroquine died compared to 13% of those who were taking the drug. The median age of those studied was 64.

"In this multi-hospital assessment, when controlling for COVID-19 risk factors, treatment with hydroxychloroquine alone and in combination with azithromycin was associated with reduction in COVID-19 associated mortality," the study's authors wrote. The peer-reviewed study was published this week in the International Journal of Infectious Diseases.

The study adds texture to the findings of the Department of Veterans Affairs in a study that showed an increased mortality rate among veterans who were taking the anti-malarial drug. The agency noted that the veterans were at a higher risk because of underlying conditions.:snip:

Link to comment
Share on other sites

Create an account or sign in to comment

You need to be a member in order to leave a comment

Create an account

Sign up for a new account in our community. It's easy!

Register a new account

Sign in

Already have an account? Sign in here.

Sign In Now
  • 1711718991
×
×
  • Create New...